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Inadequate Response to Treatment in
Coronary Heart Disease
Adverse Effects of Type D Personality and Younger Age on 5-Year
Prognosis and Quality of Life
Johan Denollet, PhD; Johan Vaes, MD; Dirk L. Brutsaert, MD
Background—Improvement in treatment of patients with coronary heart disease (CHD) has caused longer survival but also
an increase in the number of patients at risk for subsequent cardiac events and impaired quality of life (QOL). We
hypothesized that chronic emotional distress confers an increased risk of poor outcome despite appropriate treatment.
Methods and Results—This prospective study examined the 5-year prognosis of 319 patients with CHD. Baseline assessment
included symptoms of depression/anxiety and distressed personality type (type D—ie, high negative affectivity and social
inhibition). The main end points were cardiac death or nonfatal myocardial infarction and impaired QOL. There were 22
cardiac events (16 nonfatal); they were related to left ventricular ejection fraction (LVEF)#50%, poor exercise tolerance, age
#55 years, symptoms of depression, and type D personality. Multivariate analysis yielded LVEF#50% (OR, 3.9;P50.009),
type D personality (OR, 8.9;P50.0001), and age#55 years (OR, 2.6;P50.05) as independent predictors of cardiac events.
Convergence of these risk factors predicted the absence of the expected therapeutic response that was observed in 10% of the
patients. When 2 or 3 risk factors occurred together, the rate of poor outcome was 4-fold higher (P50.0001). Estimates of
medical costs increased progressively with an increasing number of risk factors. Smoking, symptoms of depression, and type
D personality were independent predictors of impaired QOL.
Conclusions—Decreased LVEF, type D personality, and younger age increase the risk of cardiac events; convergence of
these factors predicts nonresponse to treatment. Emotionally stressed and younger patients with CHD represent high-risk
groups deserving of special study.(Circulation. 2000;102:630-635.)
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I ndexes of disease severity, such as decreased left ventric-ular function or exercise tolerance, are associated with
poor prognosis in patients with coronary heart disease
(CHD).1 Emotional distress has, in addition to standard risk
factors, been widely associated with CHD.2–4 Whereas acute
emotional stress may precipitate cardiac events in high-risk
individuals,3 chronic emotional stress increases susceptibility
to the underlying pathophysiological processes.4 Emotional
stress may thus elicit coronary spasm, platelet activation, and
decreased heart rate variability,5–7 thereby leading to myocar-
dial ischemia, thrombotic occlusion, cardiac arrhythmias,
myocardial infarction, and sudden cardiac death.2–4,8
Chronic emotional stress is largely dependent on broad
personality traits that refer to individual differences in emo-
tions and behavior that are relatively stable across time.9 Type
A behavior has often been mistaken for a personality type, but
type A was in fact designed to avoid association with broad
personality traits.10 Therefore, multivariate analyses were
used in previous research to delineate the “distressed” per-
sonality (type D).11 Type D patients simultaneously tend to
experience negative emotions and inhibit the expression of
emotion/behavior (Table 1). Type D personality is associated
with vulnerability to chronic emotional distress9 and an
increased risk for cardiac events11,12 in CHD patients.
Several issues need to be solved, however. First, because
improvement in treatment and secondary prevention has
caused a decline in mortality resulting from CHD,13 it is
unclear whether emotional distress has any prognostic value
in CHD patients on appropriate treatment. Second, psycho-
logical risk factors often tend to converge within individuals.
Because such convergence may, in turn, elevate the risk for
adverse cardiac events,2 CHD patients who are at risk for the
convergence of psychological risk factors should therefore be
identified. Third, although quality of life (QOL) is increas-
ingly being acknowledged as an important outcome measure
in cardiac patients,14,15 little is known about its long-term
determinants.16
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We report here on a prospective 5-year follow-up study
designed to address these issues. Patients received thrombolysis
(29%),b-blockers (54%), aspirin (72%), revascularization pro-
cedures (76%), and rehabilitation (100%), ie, interventions
known to improve prognosis.17 A new instrument9 was used for
a standardized diagnosis of patients at risk for the convergence
of psychological stresses. End points included cardiac events and
poor QOL. We hypothesized that both cardiac disorder and
emotional distress confer an increased risk of cardiac events and
impaired QOL despite appropriate cardiac treatment.
Methods
Subjects
Between January 1989 and December 1992, 322 patients with CHD
(297 men, 25 women; age, 35 to 70 years; mean age, 56.7 years)
were selected from a consecutive series of patients attending the
Antwerp cardiac rehabilitation program. Patients were eligible for
this study if they had experienced a myocardial infarction (n5162)
or coronary bypass/angioplasty (n5160) within 2 months before
entering the program. Patients with impaired left ventricular function
were included; patients with major comorbidity (eg, cancer) were
excluded. They all underwent a standardized treatment regimen, ie,
an outpatient program comprising 36 sessions (3 sessions for 1 h/wk)
of ECG-monitored, aerobic, and pulse-targeted exercise training,
along with 6 psychosocial group sessions for patients and spouses.
Individual medical, nutritional, and psychological counseling tai-
lored the program to the needs of each patient. Medical care in the
follow-up interval consisted of a cardiological check-up every 6
months. Three patients died of noncardiac causes during follow-up;
the final sample consisted of 319 patients.
Prognostic Factors
Left ventricular function and exercise tolerance were included as
indexes of disease severity. As suggested by others,1 a decrease in
left ventricular function was defined as a left ventricular ejection
fraction (LVEF) #50% as calculated from ventricular angiography.
Poor exercise tolerance was assessed with a symptom-limited exer-
cise test 6 weeks after the coronary event (ie, peak workload#140
W for younger patients and#120 W for older patients). Other
biomedical factors included thrombolysis after myocardial infarc-
tion; treatment with aspirin,b-blockers, or ACE inhibitors at
discharge from the rehabilitation program; failure to quit smoking;
and history of hyperlipidemia or hypertension. Demographic factors
included sex and age (ie,#55 versus$56 years).
Emotional Distress
This study included measures of both episodic distress, lasting several
months, and chronic distress, lasting several years.4 Symptoms of
depression/anxiety are markers of episodic distress most prominently
linked to CHD.2 Patients scoring in the upper tertile on the despondency
scale (r50.63 with the Zung Depression Scale)18 and/or the state
anxiety scale19 were considered to report many symptoms of depression
($19 symptoms) and/or anxiety ($44 symptoms), respectively.
Chronic emotional distress was assessed with the Type D Scale 16
(DS16)9; its validity and reliability are summarized in the Appendix. A
median split on the DS16 negative affectivity and social inhibition
scales was used to classify 99 patients as type D ($9 and $15,
respectively) and 220 patients as non–type D.
End Points
The main end points in this study were cardiac events (cardiac death
or nonfatal myocardial infarction) and impaired QOL. Revascular-
ization (coronary bypass or angioplasty) during follow-up was a
secondary end point. The Health Complaints Scale (HCS) and the
Global Mood Scale (GMS) are psychometrically sound and sensitive
measures of QOL.20 The HCS comprises 12 somatic items (eg,
tightness of chest, shortness of breath, fatigue) and 12 items of
perceived disability that are frequently reported by CHD patients21;
these items are rated on a 5-point scale of distress. The GMS
comprises 10 negative and 10 positive mood terms that are rated on
a 5-point scale of intensity.22 Depressive affect is characterized by
the interaction of high negative and low positive mood22; a median
split on the negative and positive mood scales was used to assess
depressive affect at follow-up.
A multicategorical index23 ranging from event-free survival with
good QOL (rating51) to cardiac death (rating510) was used to
summarize outcome data. Events were rated as 10 (cardiac death), 7
(myocardial infarction), 4 (revascularization), and 1 (event-free surviv-
al); poor perceived health was rated as 1 and depressive affect also as 1.
For example, revascularization with poor perceived health and depres-
sive affect was rated as 4111156. The economic impact of outcome
was estimated with the use of data on the direct medical care costs of
fatal ($17 532) and nonfatal ($15 540) cardiac events,24 coronary bypass
($32 347), and angioplasty ($21 113)14 and mild ($1820) to severe
($2100) depressive symptoms.25
Procedure and Analyses
At entry into the rehabilitation program, all patients filled out the
emotional distress and type D scales. After 5 years, patients and their
families were contacted by telephone and mail to determine the study
end points. Mortality and infarction data were derived from hospital
records and discussed with the patient’s attending physician. The
follow-up questionnaire contained the QOL scales; if patients failed to
return the questionnaire, they were contacted again 4 and 8 weeks later
to maximize outcome data on QOL. Thex2 statistic was used to
examine any changes in 5-year cardiac mortality between the 1985 to
1988 rehabilitation cohort11 and the 1989 to 1992 cohort of the present
study. Baseline measures were dichotomized, and the OR for cardiac
TABLE 1. Type D Personality
Personality Trait
Negative Affectivity Social Inhibition
Definition Tendency to experience negative
emotions across time/situations
Tendency to inhibit emotions and
behaviors in social interaction
Clinical picture Often feels unhappy, tends to worry; is
pessimistic, easily irritated; lacks
self-esteem/assertiveness; has
symptoms of depression and anxiety
Feels insecure in social interaction;
tends to keep others at distance;
tends to be closed and reserved;
reports low levels of social support
Diagnosis DS16 negative affectivity scale
(median split)
DS16 social inhibition scale
(median split)
Prognosis Type D, defined by high scores on negative affectivity and social inhibition:
independent predictor of long-term mortality in patients with CHD11; associated
with cardiac events in post-MI patients with LVEF#50%12
MI indicates myocardial infarction.
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events for each pair of groups was assessed through logistic regression
analysis and thex2 statistic. MANOVA and an unpairedt test were used
to examine continuous scores of QOL. These scores were dichotomized
to identify patients with impaired QOL, and ORs were calculated.
Multiple logistic regression analyses were used to determine the best
independent predictors of cardiac events and impaired QOL. Criteria for
entry and removal were based on the likelihood ratio test with limits set
at P#0.05 andP.0.05. Finally, patients were stratified by number of
prognostic factors to examine the effect of convergence of risk factors
on prognosis and direct medical care costs.
Results
No patients were lost to follow-up. Patients in the present
study had a low rate of 5-year cardiac death (ie, 6/31952%)
compared with patients from the 1985 to 1988 rehabilitation
cohort11 (ie, 15/30355%; P50.032). This finding is consis-
tent with the notion that the patients in the present study
received appropriate treatment.13 After 5 years, 22 patients
had experienced a cardiac event; there were 16 nonfatal
myocardial infarctions.
Cardiac Events
Cardiac events were significantly associated with LVEF#50%,
poor exercise tolerance, symptoms of depression, type D per-
sonality, and age#55 years (Table 2). No drug treatment
variables were related to outcome, suggesting an accurate
pharmacological approach to the individual medical situation of
patients in this study. Type D patients had a greater risk for both
death and nonfatal myocardial infarction compared with non–
type D patients—ie, 5/756% versus 1/20050.5% cardiac
deaths (P50.006) and 11/81513% versus 5/2052% nonfatal
infarctions (P50.007), respectively. Including revascularization
as an end point in secondary analyses also yielded significant
associations with LVEF#50%, symptoms of depression, type D
personality, and age#55 years. Poor exercise tolerance did no
longer reach statistical significance, whereas symptoms of anx-
iety were significant (P50.036).
To determine whether disease severity and emotional distress
were independent predictors of adverse cardiac events, we
entered these factors in a stepwise logistic regression model.
This model included LVEF#50% (OR, 3.9), type D personality
(OR, 8.9), and age#55 years (OR, 2.6) but not poor exercise
tolerance or symptoms of depression/anxiety (Table 3). Accord-
ingly, secondary analyses indicated that LVEF#50% and type
D personality were retained as independent predictors of total
events, including revascularization procedures.
Quality of Life
Of the 313 surviving patients, 299 (95%) completed and
returned the follow-up questionnaire, 11 (4%) failed to return




Fatal and Nonfatal Cardiac Events at 5 Years Cardiac Events and Revascularization at 5 Years
Cardiac Events
(n522), % (n) OR (95% CI) P *
Total Events
(n549), % (n) OR (95% CI) P *
Demographic factors
Male sex 92 (248) 95 (21) 0.5 (0.1–4.2) NS 94 (46) 0.7 (0.2–2.6) NS
Age#55 y 38 (102) 59 (13) 2.4 (1.0–5.8) 0.049 53 (26) 1.9 (1.0–3.4) 0.045
Biomedical factors
LVEF#50% 16 (43) 36 (8) 3.0 (1.2–7.6) 0.015 33 (16) 2.6 (1.3–5.1) 0.006
Poor exercise tolerance 25 (68) 46 (10) 2.5 (1.0–5.6) 0.038 33 (16) 1.4 (0.8–2.8) NS
Thrombolysis after MI 25 (45) 35 (6) 0.9 (0.4–2.2) NS 34 (13) 0.9 (0.9–1.0) NS
Aspirin therapy 79 (212) 73 (16) 0.7 (0.3–2.0) NS 69 (34) 0.6 (0.3–1.2) 0.162
b-Blocker therapy 53 (143) 59 (13) 1.3 (0.5–3.1) NS 61 (30) 1.4 (0.8–2.6) NS
ACE inhibitor therapy 10 (28) 5 (1) 0.4 (0.1–3.2) NS 10 (5) 1.0 (0.4–2.7) NS
Failure to quit smoking 17 (45) 18 (4) 1.1 (0.4–3.4) NS 20 (10) 1.3 (0.6–2.8) NS
History of hyperlipidemia 38 (103) 36 (8) 0.9 (0.4–2.3) NS 37 (18) 0.9 (0.5–1.8) NS
History of hypertension 32 (85) 27 (6) 0.8 (0.3–2.2) NS 29 (14) 0.9 (0.5–1.7) NS
Episodic distress
Symptoms of depression 32 (85) 55 (12) 2.6 (1.1–6.3) 0.027 51 (25) 2.3 (1.2–4.2) 0.008
Symptoms of anxiety 33 (90) 50 (11) 2.0 (0.8–4.8) 0.114 49 (24) 1.9 (1.0–3.6) 0.036
Chronic distress
Type D personality 26 (70) 73 (16) 7.6 (2.9–20.2) 0.0001 59 (29) 4.1 (2.2–7.8) 0.0001
MI indicates myocardial infarction.
*Univariate analysis.
TABLE 3. Independent Predictors of 5-Year Prognosis
Variable OR 95% CI P
Cardiac events*
LVEF#50% 3.9 1.4–11.1 0.009
Type D personality 8.9 3.2–24.7 0.0001
Age#55 y 2.6 1.0–6.6 0.05
Total events†
LVEF#50% 2.9 1.4–6.0 0.004
Type D personality 4.5 2.3–8.5 0.0001
*Fatal and nonfatal cardiac events (n522).
†Cardiac events plus revascularization procedures (n549).
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the questionnaire, and 3 (1%) provided incomplete data.
Nonresponders did not differ significantly from responders
on any of the baseline measures. With continuous scores of
somatic complaints, perceived disability, and negative and
positive mood as an outcome measure, MANOVA indicated
that poor QOL after 5 years of follow-up was associated with
female sex (P50.004), age#55 years at baseline (P50.05),
poor exercise tolerance at baseline (P50.003), failure to quit
smoking (P50.02), symptoms of depression (P50.0001) and
anxiety (P50.0001) at baseline, type D personality
(P50.0001), and nonfatal myocardial infarction (P50.003)
or revascularization (P50.0001) during follow-up.
Using median splits at follow-up, 104 patients were classified
as reporting poor perceived health (ie, HCS somatic complaints
.6 and HCS feelings of disability.8) and 82 patients as
reporting depressive affect (ie, GMS negative mood.6 and
GMS positive mood,24). A stepwise logistic regression model
yielded failure to quit smoking (OR, 2.3 and 2.6), symptoms of
depression (OR, 3.3 and 2.7), and type D personality (OR, 2.2
and 2.6) as independent prognostic factors for both poor per-
ceived health and depressive affect (Table 4). Poor health was
also predicted by LVEF#50% and hyperlipidemia, and depres-
sive affect was predicted by female sex and symptoms of
anxiety. Accordingly, psychosocial factors had a prognostic
power above and beyond that of standard biomedical factors in
the prediction of poor QOL.
On a Scale From 1 to 10
Next, all patients were rated in terms of their outcome ranging
from event-free survival with good QOL (rating51) to
cardiac death (rating510). Most patients were rated 1 or 2;
10% of patients were rated$6 (Table 5). There were 4
independent prognostic factors for poor outcome (categories
6 through 10) as opposed to good outcome (categories 1 to 2);
ie, LVEF #50% (OR, 4.7; 95% CI, 1.8 to 12.4;P50.002),
type D personality (OR, 8.3; 95% CI, 3.4 to 20.4;P50.0001),
age#55 years (OR, 2.6; 95% CI, 1.1 to 6.1;P50.024), and
symptoms of depression at baseline (OR, 2.4; 95% CI, 1.0 to
5.6; P50.042). Hence, cardiac disorder, emotional distress,
and younger age provided additional prognostic information.
Convergence of Risk Factors
To examine the effect of convergence of risk factors, patients
were stratified according to LVEF#50%, type D personality,
and age#55 years. Only 3 of 107 patients without any of these
prognostic factors had a poor outcome; in contrast, prognostic
factors occurring in combination significantly magnified the risk
for poor outcome (the Figure, top). Of 10 patients combining 3
risk factors (LVEF#50% plus type D plus#55 years), 5 had a
poor outcome. Convergence of risk factors was paralleled by an
increase in estimated medical costs (the Figure, bottom). Over-
all, patients with 2 or 3 prognostic factors had 4 times the risk for
poor outcome compared with patients with either 0 or 1
prognostic factor; ie, the rate for poor outcome was 18/64528%
versus 15/2556% (P,0.0001). Accordingly, mean estimated
medical costs were $10 400 and $3600 for both groups, respec-
tively (P,0.0001).
Discussion
Cardiac disorder (decreased LVEF), emotional distress (type
D personality), and premature onset of CHD (younger age at
index event) were independent predictors of poor prognosis.
Convergence of these distinctly different factors heightened
the risk for poor outcome; when 2 or 3 factors occurred
together, the rate of adverse health outcome was 4-fold
higher. Estimates of direct medical costs increased progres-
TABLE 4. Independent Predictors of Impaired QOL
Variable OR 95% CI P
Poor perceived health*
Failure to quit smoking 2.3 1.2–4.5 0.014
Symptoms of depression 3.3 1.9–5.8 0.0001
Type D personality 2.2 1.2–3.8 0.007
LVEF#50% 2.0 1.0–3.9 0.049
History of hyperlipidemia 2.0 1.1–3.4 0.016
Depressive affect†
Failure to quit smoking 2.6 1.3–5.1 0.009
Symptoms of depression 2.7 1.5–5.2 0.002
Type D personality 2.6 1.4–4.8 0.002
Female sex 3.0 1.1–8.1 0.032
Symptoms of anxiety 2.5 1.3–4.6 0.005
*n5104 of 299 patients.
†n582 of 299 patients.
TABLE 5. Overall Rating of Adverse Health Outcomes







1 54 (173) Event-free survival, good QOL Good
2 16 (50) Event-free survival, poor perceived
health or depressive affect only
Good
3 15 (47) Event-free survival, poor perceived
health, and depressive affect
Intermediate
4 3 (10) Revascularization during follow-up,
good QOL
Intermediate
5 2 (6) Revascularization during follow-up,
poor perceived health or depressive
affect only
Intermediate
6 3 (11) Revascularization during follow-up,
poor perceived health, and
depressive affect
Poor
7 2 (7) Nonfatal myocardial infarction, good
QOL
Poor
8 1 (4) Nonfatal myocardial infarction, poor
perceived health or depressive affect
only
Poor
9 2 (5) Nonfatal myocardial infarction, poor
perceived health, and depressive
affect
Poor
10 2 (6) Cardiac death Poor
*For outcome categories, 70% (n5223) were good, 20% (n563) were
intermediate, and 10% (n533) were poor.
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sively with increasing number of factors. Examination of the
QOL end points revealed that behavioral/psychological in-
dexes (smoking, depressive symptomatology, type D person-
ality) outweighed biomedical indexes in the long-term pre-
diction of physical and emotional well-being. Overall, these
findings provide clinical evidence that CHD patients consti-
tute a heterogeneous group and that failure to account for
emotional distress and age at disease onset may lead to
inaccurate risk estimates.
In line with epidemiological data in the United States,13 we
observed a significant decrease in 5-year cardiac mortality.
Aspirin andb-blockers improve survival in CHD patients17;
in the present study, 72% and 54% of patients were treated
with these drugs, respectively. Cardiac rehabilitation also
improves survival17 and decreases the incidence of ventricu-
lar arrhythmias26 and cardiac death27 in patients with left
ventricular dysfunction. However, despite appropriate medi-
cal treatment and a low mortality rate, younger age and
emotional distress still emerged as independent predictors of
cardiac events.
In the present sample of middle-aged and predominantly
male subjects, patients#55 years of age had a greater risk of
cardiac events than patients$56 years of age. This finding
may indicate that younger men with CHD represent a distinct
group in terms of risk factors and prognosis. Consistent with
previous findings,2 episodic distress (symptoms of depression
and anxiety) was associated with an increased risk for cardiac
events. This risk, however, was accounted for by individual
differences in chronic emotional distress (ie, type D person-
ality). Hence, the present study confirms and expands previ-
ous findings11,12by showing that type D personality was still
a predictor of cardiac events despite appropriate treatment.
The adverse effect of type D personality may, in fact, extend
beyond cardiac events to include impaired QOL.
Little is known about the long-term determinants of QOL
in cardiac patients. The present findings suggest that QOL is
a complex phenomenon explained by multiple factors. Failure
to quit smoking emerged as a major predictor of poor QOL.
In addition, symptoms of depression and type D personality
were independent predictors of QOL. The fact that baseline
levels of depressive symptomatology predicted depressive
affect 5 years later supports the notion that the relation
between depressive symptoms and CHD implies an element
of chronicity.28 Poor perceived health was also predicted by a
decreased LVEF, and depressive affect was predicted by
female sex and anxiety. Hence, apart from disease severity,
research needs to focus on smoking, chronic negative emo-
tions, and personality as determinants of poor QOL in CHD.
Using a composite end point, we found that 10% of
patients experienced a deterioration in health status within the
first 5 years of the index event. Biomedical and psychosocial
factors predicted this absence of the expected therapeutic
response to medical/surgical intervention and rehabilitation.
Although the generalizability of these findings is limited by
the small number of women29 and the exclusion of elderly
patients,30 they do suggest that we need to identify ways to
optimize treatment for certain subgroups of high-risk patients.
Conversely, non–type D patients who were.55 years of age
and had an LVEF.50% had an excellent prognosis, sug-
gesting that the present treatment regimen did meet the needs
of this subgroup.
These findings have implications for clinical research and
practice. First, outcome research in CHD has focused largely
on the role of disease severity1 and sex- and age-based
differences29,30; it is time now to also account for psycholog-
ical factors.2 Second, the identification of CHD patients who
experience emotional distress may lead to more accurate risk
estimates in clinical practice. The DS169 is a brief, sound
measure that allows rapid screening of chronic emotional
distress among patients with CHD. Third, emotional distress
as a risk factor is subject to clinical modification.31 Patient-
specific interventions2 targeting specific risk factors may
include stress management.32
In conclusion, we found that 10% of patients with CHD did
not display the expected therapeutic response to cardiac
treatment and secondary prevention. A decreased LVEF,
chronic emotional distress, and younger age at disease onset
accounted for their susceptibility to cardiac events and
impaired QOL 5 years after the index event. When 2 or 3 risk
factors occurred together, the rate of adverse health outcomes
was 4-fold higher. The longer survival of patients with CHD
will lead to a growing group of patients at risk of subsequent
cardiac events and chronic conditions.15 In addition to cardiac
disorder, patients’ ages and levels of emotional distress must
be considered to optimize this risk stratification.
Convergence of risk factors: adverse effect on prognosis (top)
and medical costs (bottom). Patients were stratified by number
of independent prognostic factors that emerged from logistic
regression model (ie, LVEF #50%, type D personality, and age
#55 years). Top, Poor outcome of patients as function of con-
vergence of risk factors. Poor outcome was defined as cardiac
death, nonfatal myocardial infarction, or revascularization with
poor QOL. Number of patients are presented on top of each
bar. Bottom, Increase in estimated medical costs as function of
convergence of risk factors. Mean estimated medical costs are
presented on top of each bar. *P,0.05.
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Appendix
Validity of the DS16 in CHD Patients
Internal validity (n5400)
Factor Analysis
Factor I Factor II
Negative affectivity
Often feels unhappy 0.80 0.05
Is often down in the dumps 0.78 0.10
Often worries about something 0.77 0.09
Takes a gloomy view of things 0.72 0.10
Is often in a bad mood 0.64 0.12
Feels at ease most of the time (R) 20.70 20.12
Is hopeful about the future (R) 20.78 20.04
Feels happy most of the time (R) 20.79 20.05
a50.89
Social inhibition
Finds it hard to make “small talk” 0.14 0.78
Doesn’t find things to talk about 0.16 0.72
Finds it hard to express opinions 0.16 0.66
Has little impact on other people 0.09 0.65
Likes to be in charge of things (R) 0.03 20.59
Often talks to strangers (R) 20.08 20.60
Is often in charge in groups (R) 0.02 20.62
Makes contact easily (R) 20.09 20.70
a50.82
External validity (n5100) Non–type D Type D*
Symptoms of depression (BDI) 3.6 (3.6) 8.4 (6.5)†
Symptoms of anxiety (MAS) 4.4 (4.0) 9.8 (4.6)†
Symptoms of stress (GHQ) 45.2 (10.9) 52.0 (10.1)‡
Satisfaction with life (LSI) 35.8 (8.2) 24.6 (7.1)†
Global self-esteem (RSE) 33.1 (5.5) 24.0 (7.1)†
Extraversion (EXT) 12.7 (4.3) 6.9 (4.6)†
a indicates Cronbach’s estimate of internal consistency; R, reverse keyed;
BDI, 13-item Beck Depression Inventory; MAS, 20-item Manifest Anxiety Scale
from the Minnesota Multiphasic Personality Inventory (MMPI); GHQ, 20-item
General Health Questionnaire; LSI, Life Satisfaction Index Z; RSE, Rosenberg
Self-Esteem Scale; and EXT, 20-item Extraversion Scale from the MMPI.
*Twenty-six type D vs 74 non–type D patients.
†P,0.0001; ‡P,0.01.
Adapted from Denollet.9
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